{
    "clinical_study": {
        "@rank": "31967", 
        "biospec_descr": {
            "textblock": "The ophthalmologist will collect samples from the tissue that is removed during patients eye\n      surgery that would otherwise be discarded or thrown away. Researchers will collect the\n      sample and grow in the laboratory conditions. These cells will then be studied for further\n      research on glaucoma."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "In this study, the investigators will collect tissue from patients undergoing trabeculectomy\n      for primary open-angle glaucoma treatment. This tissue would normally be discarded. These\n      trabecular meshwork (TM) cells can be cultured and used experimentally to better understand\n      the mechanisms of glaucoma. These TM biopsies will be cultured on the same day as the\n      trabeculectomy using established techniques."
        }, 
        "brief_title": "Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Glaucoma", 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients having glaucoma and undergoing a trabeculotomy\n\n          -  Sign ICF (Informed Consent Form)\n\n        Exclusion Criteria:\n\n          -  None"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients having glaucoma and undergoing a trabeculotomy"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02151318", 
            "org_study_id": "15309"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 27, 2014", 
        "location": [
            {
                "contact": {
                    "email": "cbourne@health.usf.edu", 
                    "last_name": "Carla Bourne, MD", 
                    "phone": "813-974-5853"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33606"
                    }, 
                    "name": "Tampa General Hosipital"
                }, 
                "investigator": {
                    "last_name": "Carla Bourne, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "cdickey@health.usf.edu", 
                    "last_name": "Chad A Dickey, PhD", 
                    "phone": "813-396-0639"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33613"
                    }, 
                    "name": "Byrd Alzheimer's Institute"
                }, 
                "investigator": [
                    {
                        "last_name": "Chad A Dickey, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Andrew R Stothert, MS", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies", 
        "overall_official": [
            {
                "affiliation": "University of South Florida department of Molecular Medicine and Byrd Alzheimer's Institute", 
                "last_name": "Chad A Dickey, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of South Florida and Tampa General Hospital", 
                "last_name": "Carla Bourne, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "TM cell biopsy samples from patients with glaucoma will be harvested and cultured in a laboratory setting to grow primary human TM cells. These cells will be used to test different medications, looking at the medications ability to reduce cellular pathologies commonly seen in TM tissue of patients with glaucoma. Pathologies include myocilin aggregation, and cell death. This will help researchers to determine the most effective compounds in treating glaucoma.", 
            "measure": "Efficacy of new glaucoma medications to reduce TM cellular pathologies associated with the disease glaucoma.", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02151318"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Cultured primary TM cells treated with various new medications synthesized to treat cellular pathologies associated with glaucoma, will also be analyzed to look at toxicity caused by the treatments themselves. THis will help to determine the safety of these new medications prior to being administered to patients.", 
            "measure": "Cultured TM cell toxicity caused by new glaucoma medications", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "source": "University of South Florida", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of South Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case-Only", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}